FOLH1 and posterior cortical atrophy: Moreover, our cohort included only patients with high-risk PCa, which have a low rate of negative PSMA-PET for primary disease, and the impact of IHC analyses is therefore questionable in this context to identify false-negative findings at PSMA-PET.